Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Am J Psychiatry. 2010 Aug 16;167(10):1194–1201. doi: 10.1176/appi.ajp.2010.09071011

Table 3. Clinical Correlates and Impact of Mood Disorder Spectrum Subgroups.

MDD + Mania MDD + Hypomania MDD + Subth Hypomania MDD Only MDD + Hypomania vs. MDD + Subth Hypomania MDD + Subth Hypomania vs. MDD Only






% s.e. % s.e. % s.e. % s.e. OR (95% C.I.) OR (95% C.I.)
Treatment for Mood Disorders
 Lifetime 86.2 3.3 81.2 3.9 64.9 2.4 64.8 1.8 2.4 (1.4-4.0)* 1.0 (0.8-1.4)
 Last 12 months 67.7 8.8 46.3 5.4 38.8 3.9 38.3 2.3 1.7 (1.2-2.4)* 1.2 (0.9-1.5)
Comorbidity disorders (Lifetime)
 Anxiety 87.1 4.8 82.6 3.3 72.2 2.8 52.6 1.7 1.9 (1.2-3.0)* 2.3 (1.8-3.0)*
 Substance Use 63.9 4.6 41.8 3.7 35.3 2.3 18.0 1.5 1.4 (1.0-2.0)* 2.3 (1.7-3.1)*
 Behavioral Problem 69.0 5.5 50.4 5.1 41.1 2.1 19.2 1.0 1.7 (1.1-2.6)* 2.3 (1.8-2.9)*
Suicide Attempts (Lifetime) 66.1 7.1 50.2 6.7 40.7 3.3 31.2 3.2 1.5 (0.9-2.7) 1.4 (1.0-2.1)*
Sheehan Disability Scale: Role impairment (12 month)
 Severe (%) 94.3 3.8 91.9 3.8 67.1 4.0 61.5 2.3 5.6 (2.0-16.2)*a 1.3 (0.9-1.9)b
 Moderate (%) 5.7 3.8 7.0 3.6 24.7 3.7 27.6 2.2
 Mild (%) NA NA 1.1 1.2 6.2 1.8 7.8 1.3
 None (%) NA NA NA NA 2.0 1.1 3.1 0.8
a, b

Severe group versus all others

*

p<0.05